Literature DB >> 22901123

Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.

Bin Xiang1, Yuan-Yuan Mi, Teng-Fei Li, Peng-Fei Liu.   

Abstract

OBJECTIVE: The p53 tumor suppressor pathway plays an important role in gastric cancer (GC) development. Auto-regulatory feedback control of p53 expression is critical to maintaining proper tumor suppressor function. So far, several studies between p53 Arg72Pro polymorphism and GC have generated controversial and inconclusive results.
METHODS: To better assess the purported relationship, we performed a meta-analysis of 19 publications. Eligible studies were identified by searching the Pubmed database. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to assess any link.
RESULTS: Overall, a significant association was detected between the p53 Arg72Pro polymorphism and GC risk (Pro-allele vs. Arg-allele: OR=1.05, 95%CI=1.01-1.08; Pro/Pro vs. Arg/Arg: OR=1.13, 95%CI=1.04-1.22). Moreover, on stratified analysis by race, significantly increased risk was found for Asian populations (Pro-allele vs. Arg-allele: OR=1.06, 95%CI=1.02-1.10; Pro/Pro vs. Arg/Arg: OR=1.16, 95%CI=1.07-1.26; Pro/Pro+Pro/Arg vs. Arg/Arg: OR=1.58, 95%CI=1.09-2.27).
CONCLUSIONS: Our study provided evidence that the p53 72Pro allele may increase GC risk in Asians. Future studies with larger sample size are warranted to further confirm this association in more detail.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901123     DOI: 10.7314/apjcp.2012.13.5.1787

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

Review 1.  Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.

Authors:  Danilo do Rosário Pinheiro; Wallax Augusto Silva Ferreira; Mariceli Baia Leão Barros; Mariana Diniz Araújo; Symara Rodrigues-Antunes; Bárbara do Nascimento Borges
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

2.  Polymorphisms of microRNA target genes IL12B, INSR, CCND1 and IL10 in gastric cancer.

Authors:  Vytenis Petkevicius; Violeta Salteniene; Simonas Juzenas; Thomas Wex; Alexander Link; Marcis Leja; Ruta Steponaitiene; Jurgita Skieceviciene; Limas Kupcinskas; Laimas Jonaitis; Gediminas Kiudelis; Peter Malfertheiner; Juozas Kupcinskas
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.